Tag: Akero Therapeutics Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Akero Therapeutics Inc.

Andrew Cheng, MD, PhD Joins Akero Therapeutics as President and Chief Executive Officer

Added to Collection on: 2018-09-10 19:03:45

Tags for this article:

Biotechnology
Gilead Sciences
Life Sciences
Non-alcoholic fatty liver disease
Akero Therapeutics Inc.
Andrew Cheng

Click the tags to see associated articles and topics

View Article Details
How Much Of Akero Therapeutics, Inc. (NASDAQ:AKRO) Do Institutions Own?

Added to Collection on: 2020-07-29 18:30:00

Tags for this article:

Financial markets
Stock market
Financial economics
Corporate finance
Equity securities
Shareholders
Stock
Equity
Common stock
Akero Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Akero Therapeutics Target of Unusually Large Options Trading (NASDAQ:AKRO)

Added to Collection on: 2021-03-25 04:30:54

Tags for this article:

Finance
Financial markets
Money
Equity securities
Stock market
Corporate finance
Exchange-traded fund
Stock
Short
BlackRock
Share
Akero Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Akero Therapeutics Appoints Judy Chou, Ph.D., to its Board of Directors

Added to Collection on: 2021-07-14 12:00:00

Tags for this article:

Articles
Life Sciences
Economic taxonomy
Biotechnology
Communication
Forward-looking statement
Form 10-K
Biomanufacturing
EFX
FGF21
Pharmaceutical industry in China
Non-alcoholic fatty liver disease
SOUTH SAN FRANCISCO
Akero Therapeutics Inc.
Judy Chou

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen ...

Added to Collection on: 2021-07-15 12:11:15

Tags for this article:

Finance
Economy of New York City
NASDAQ
Life Sciences
Biotechnology
MorphoSys
Alexion Pharmaceuticals
Nasdaq Nordic
Aytu BioPharma Inc.
Adicet Bio Inc.
BioXcel Therapeutics Inc
Achilles Therapeutics plc
Adverum Biotechnologies Inc.
Bolt Biotherapeutics, Inc.
AstraZeneca plc
Black Diamond Therapeutics, Inc.
Avenue Therapeutics Inc.
Baudax Bio Inc.
Akero Therapeutics Inc.
Aptose Biosciences Inc
Celldex Therapeutics Inc.
Allogene Therapeutics Inc.
Alexion Pharmaceuticals Inc.
PLx Pharma Inc
Bristol-Myers Squibb Company
Zoetis Inc.
Celyad Oncology SA
Moderna, Inc.
Allovir Inc
Allena Pharmaceuticals Inc
4d molecular therapeutics
AbCellera Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Akero Therapeutics (NASDAQ:AKRO) and ProMIS Neurosciences (NASDAQ:PMN) Financial Review

Added to Collection on: 2022-09-12 07:40:05

Tags for this article:

Promis
Price?earnings ratio
Akero Therapeutics Inc.
Amorfix Life Sciences Ltd.
ProMIS Neurosciences Inc.

Click the tags to see associated articles and topics

View Article Details
Reviewing Akero Therapeutics (NASDAQ:AKRO) & ProMIS Neurosciences (NASDAQ:PMN)

Added to Collection on: 2022-09-12 07:40:00

Tags for this article:

Promis
Price?earnings ratio
Akero Therapeutics Inc.
Amorfix Life Sciences Ltd.
ProMIS Neurosciences Inc.

Click the tags to see associated articles and topics

View Article Details
Akero Therapeutics Target of Unusually High Options Trading (NASDAQ:AKRO)

Added to Collection on: 2022-09-14 07:16:50

Tags for this article:

Life Sciences
Industries
Akero Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Morgan Stanley Increases Akero Therapeutics (NASDAQ:AKRO) Price Target to $40.00

Added to Collection on: 2022-11-09 06:46:00

Tags for this article:

Stock market
Equity securities
Corporate finance
Stock
Share
Akero Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details